SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Amgen Says FDA Approved Prescribing Information Update Cutting IMDELLTRA Monitoring Time For First Two Doses To 6 To 8 Hours From 22 To 24 Hours
RUBICON RESEARCH has received FDA approval for ANDA220884, signaling a significant milestone in its portfolio and positioning the company to capitalize on a substantial market oppo…
Novadoz Pharmaceuticals LLC recently received approval from the FDA for its Abbreviated New Drug Application (ANDA) filing for tapentadol hydrochloride, enhancing its portfolio fol…
On September 2, 2026, Precision Dose Inc. won FDA approval for ANDA214523, laying the groundwork for market expansion and revenue generation for the company's portfolio. The approv…
Dr. Reddy’s Laboratories Inc. has received FDA approval for its ANDA213234, granting market exclusivity to its oral generic version of pomalidomide starting August 31, 2026. This r…
FDA Approves Stelara for Pediatric Ulcerative Colitis
FDA has granted full approval to Takeda Pharmaceuticals U.S.A., Inc. for a new drug application, a milestone that will significantly bolster the company’s commercial portfolio and …
ORBICULAR PHARM TECH has received regulatory approval from the U.S. Food and Drug Administration for ANDA220938, bringing a novel substance to the market. This clearance is anticip…
SUN PHARMACEUTICAL INDUSTRIES LIMITED announced the United States FDA approval of its latest medication on August 26, marking a strategic entry into the U.S. market that is expecte…
Revolution Medicines today achieved a significant strategic milestone with the FDA approval of NDA220910 for DARAXONRASIB (oral), a development that broadens the company's portfoli…
Zydus Lifesciences received FDA approval for its ANDA submission, setting the stage for commercialization and the potential to capture market share in the relevant therapeutic spac…
Glenmark Pharmaceuticals Inc. has received a final FDA approval for the ANDA for Fluticasone Propionate Nasal Spray, which is set to expand its portfolio in a market currently driv…
STERINIVA INC received regulatory approval from the FDA on August 18, 2026, but the document does not specify the product name or substance, making it impossible to assess the fina…
Creekwood Pharmaceuticals announced today that the FDA has approved its Abbreviated New Drug Application (ANDA #219460), signaling the entry of the company into this therapeutic se…
MSN announced on August 14, 2026, that it has received final approval for ANDA 218873, opening the door to generic competition for the previously cited substance that will likely p…
Baxter Healthcare Corporation has secured FDA approval for intravenous sodium bicarbonate, a critical product for the acute management of metabolic acidosis. The approval bolsters …
Sandoz has received FDA approval for a line extension of its high-titer Emgality biosimilar, a 40 mg/administration formulation set to enter the Alpha sector of the migraine market…
**VIWIT PHARM** announced U.S. approval for its ANDA application this week, marking a significant step toward market entry. This regulatory clearance is poised to offer widespread …
Merck Receives FDA Approval For Supplemental Biologics License Application For ENFLONSIA To Expand Indication To Prevention Of Respiratory Syncytial Virus Lower Respiratory Tract D…
Investors should look to take or hold Takeda Pharmaceuticals USA (NDA220860) shares as the regulatory body granted approval for this new treatment, setting the stage for the drug's…